Janice J.N. Li

577 total citations
16 papers, 335 citations indexed

About

Janice J.N. Li is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Janice J.N. Li has authored 16 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Janice J.N. Li's work include Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Janice J.N. Li is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Janice J.N. Li collaborates with scholars based in Canada, United States and Switzerland. Janice J.N. Li's co-authors include Natasha B. Leighl, Sabine Schmid, Maisam Makarem, Miguel García-Pardo, Deirdre Kelly, Lisa W. Le, Sally C. M. Lau, Mike Sung, Adrian G. Sacher and Jennifer Law and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Janice J.N. Li

16 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Janice J.N. Li Canada	9	219	178	132	114	30	16	335
Kevin Jao Canada	10	337 1.5×	293 1.6×	142 1.1×	145 1.3×	24 0.8×	23	476
Héctor Galindo Chile	7	163 0.7×	142 0.8×	129 1.0×	210 1.8×	39 1.3×	22	390
Sushma Jonna United States	8	203 0.9×	208 1.2×	180 1.4×	202 1.8×	38 1.3×	14	452
Penelope Ann Bradbury Canada	9	304 1.4×	227 1.3×	116 0.9×	87 0.8×	29 1.0×	39	375
Aurélie Swalduz France	11	200 0.9×	182 1.0×	92 0.7×	126 1.1×	34 1.1×	63	334
Giulia Grizzi Italy	12	185 0.8×	262 1.5×	70 0.5×	82 0.7×	30 1.0×	24	370
Xun Shi China	10	253 1.2×	231 1.3×	109 0.8×	72 0.6×	44 1.5×	27	361
Adel Zaatar Malaysia	5	376 1.7×	328 1.8×	105 0.8×	126 1.1×	26 0.9×	9	476
Pei Ni Ding Australia	5	311 1.4×	230 1.3×	143 1.1×	124 1.1×	24 0.8×	6	402
Marco Brugia Italy	12	128 0.6×	218 1.2×	100 0.8×	117 1.0×	32 1.1×	31	354

Countries citing papers authored by Janice J.N. Li

Since Specialization

Citations

This map shows the geographic impact of Janice J.N. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice J.N. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice J.N. Li more than expected).

Fields of papers citing papers by Janice J.N. Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice J.N. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice J.N. Li. The network helps show where Janice J.N. Li may publish in the future.

Co-authorship network of co-authors of Janice J.N. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Janice J.N. Li. A scholar is included among the top collaborators of Janice J.N. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice J.N. Li. Janice J.N. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Li, Janice J.N., Geoffrey Liu, & Benjamin H. Lok. (2024). Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications. Genes. 15(9). 1160–1160. 1 indexed citations

Feng, William W., Janice J.N. Li, Hong‐Hong Yan, et al.. (2024). PL04.10 Osimertinib With or Without Savolitinib as 1L in De Novo MET Aberrant, EGFRm Advanced NSCLC (CTONG 2008): A Phase II Trial. Journal of Thoracic Oncology. 19(10). S6–S6. 2 indexed citations

Schmid, Sabine, Sally C. M. Lau, Lesley Seymour, et al.. (2022). iRECIST and atypical patterns of response to immuno-oncology drugs. Journal for ImmunoTherapy of Cancer. 10(6). e004849–e004849. 24 indexed citations

Ezeife, Doreen A., Eldon Spackman, Rosalyn A. Juergens, et al.. (2022). The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 14. 27 indexed citations

Law, Jennifer, Lisa W. Le, Janice J.N. Li, et al.. (2022). Automating Access to Real-World Evidence. JTO Clinical and Research Reports. 3(6). 100340–100340. 11 indexed citations

García-Pardo, Miguel, Maisam Makarem, Janice J.N. Li, Deirdre Kelly, & Natasha B. Leighl. (2022). Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges. British Journal of Cancer. 127(4). 592–602. 75 indexed citations

Schmid, Sabine, Katrina Hueniken, Danielle Benedict Sacdalan, et al.. (2022). Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction. iScience. 25(12). 105487–105487. 11 indexed citations

Li, Janice J.N., et al.. (2022). Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer. Current Oncology. 29(9). 6260–6276. 13 indexed citations

Ezeife, Doreen A., Eldon Spackman, Rosalyn A. Juergens, et al.. (2021). OA16.02 The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(10). S876–S876. 3 indexed citations

10.

Makarem, Maisam, Doreen A. Ezeife, Adam C. Smith, et al.. (2021). Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System. Current Oncology. 28(5). 3268–3279. 11 indexed citations

11.

Sung, Mike, Pascale Tomasini, Lisa W. Le, et al.. (2021). Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection. JTO Clinical and Research Reports. 3(2). 100259–100259. 3 indexed citations

12.

Hao, Desirée, Janessa Laskin, Scott A. Laurie, et al.. (2021). P89.03 Demonstrating VALUE of Liquid Biopsy for Lung Cancer in a Public Healthcare System. Journal of Thoracic Oncology. 16(3). S689–S689. 6 indexed citations

13.

Li, Janice J.N., Mike Sung, Lisa W. Le, et al.. (2020). Tobacco exposure and immunotherapy response in PD-L1 positive lung cancer patients. Lung Cancer. 150. 159–163. 31 indexed citations

14.

Le, Lisa W., Sajjad Zahir, Janice J.N. Li, et al.. (2020). 1382P Automating access to real-world evidence. Annals of Oncology. 31. S879–S880. 1 indexed citations

15.

Schmid, Sabine, Janice J.N. Li, & Natasha B. Leighl. (2020). Mechanisms of osimertinib resistance and emerging treatment options. Lung Cancer. 147. 123–129. 114 indexed citations

16.

Juergens, Rosalyn A., Doreen A. Ezeife, Janessa Laskin, et al.. (2020). Demonstrating the value of liquid biopsy for lung cancer in a public health care system.. Journal of Clinical Oncology. 38(15_suppl). 3546–3546. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact